Interactive Patient Case Series: Anti-CGRP Biologics for Migraine Prevention

Interactive Patient Case Series: Anti-CGRP Biologics for Migraine Prevention

NeurologyGeneral PracticeFamily Medicine
A badge with ribbon in color black CAT 3A: 1 Point | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 11 Oct 2021 

Overview

About this course

Calcitonin Gene-Related Peptide (CGRP) molecules released by the cerebral nerves and blood vessels are involved in the pain-associated symptoms of migraine. CGRP monoclonal antibodies are prescribed for the treatment of difficult-to-treat migraines, reducing symptoms in cases of inadequate response to medication, and even used as a preventative therapy.

In this online module, Professor Messoud Ashina uses various case studies to illustrate diagnoses and treatment of migraine according to patient specificities, including eligibility for anti-CGRP therapy. Treatment guidelines based off the International Classification of Headache Disorders, American Headache Society and European Headache Federation are shared, providing expert insight to the use of anti-CGRP in migraine management.


1 CME Point Available

A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.

Sponsored by

Teva_Pharma_Logo.png